Brookline Capital Markets Reiterates Buy Rating on Intellia Therapeutics (NTLA), PT $106
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/1/2026
- Wall Street closes sharply lower as AI cash burn fears spark tech selloff
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil jumps 2%, settles at 6-month highs on fears of escalation in Iran
| (NASDAQ: NTLA) | Delayed: 12.47 -0.76 (5.74%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $13.23 | 52 Week High | $30.40 | |||
| Open | $12.88 | 52 Week Low | $11.86 | |||
| Day High | $13.16 | P/E | N/A | |||
| Day Low | $12.04 | EPS | $0.00 | |||
| Volume | 4,078,355 | |||||
